November 16, 2022
Seprod Limited (SEP)
Unaudited Financials for the Nine Months ended September 30, 2022:
Seprod Limited (SEP), for the nine months ended September 30, 2022, revenue totalled $51.44 billion compared to the $31.15 billion recorded for the same period of the prior financial year; this represents a 65.13% increase year over year. Revenue for the quarter totalled $23.64 billion a 108.75% increase relative to $11.32 billion the prior year. SEP highlighted that, “The results must be taken in the context of the acquisition of A.S Bryden & Sons Holdings Limited (the Bryden Group) in June 2022.”
Cost of Sales rose 65.06% from $23.03 billion in 2021 to $38.02 billion for the nine months ended September 30, 2022. Consequently, gross profit increased 65.33% to close at $13.42 billion (2021: $8.12 billion), while the second quarter gross profit amounted to $6.4 billion (2021: $2.68 billion).
However, other operating income for the period totalled $538.69 million relative to $155.78 million in 2021, a 245.8% increase year over year, while other operating expenses increased by 67.31% to close the nine months period at $9.15 billion (2021: $5.47 billion).
Consequently, operating profit rose by 71.51% to $4.81 billion (2021: $2.8 billion) for the nine months ended September 2022. While for the quarter, operating profit grew by 146% to $1.98 billion (2021: $804,453).
Finance costs totalled $1.3 billion (2021: $732.87 million), a 77.52% increase when compared to the same period last year. The company reported share of results of Joint Venture amounting to $35.64 million relative to $85.11 million reported in 2021.
Pre-tax profits climbed by 64.35% to $3.54 billion in comparison to $2.16 billion booked in the same period last year. For the quarter, pre-tax profit amounted to $1.48 billion relative to $625.48 million booked in 2021.
Taxation of $834.92 million was reported for the nine months period relative to $395.32 million booked in 2021. Consequently, SEP, for the period under review, booked net profit from continuing operations of $2.71billion (2021: $1.76 billion) and loss from discontinued operations closed at $78.42 million (2021: $59.76 million). As a result, overall net profit was $2.63 billion (2021: $1.7 billion) for the period under review, while for the quarter, net profit closed at $1.05 billion (2021: $494.52 million).
The comprehensive income for the nine months amounted to $2.51 billion (2021: $1.83 billion.) For the third quarter, comprehensive income amounted to $1.06 billion (2021: $540.05 million).
Net profit attributable to shareholders of the company amounted to $2.25 billion increasing 32% from $1.70 billion reported in 2021. Net profit attributable to shareholders of the company for the quarter was $771.61 million. (2021: $494.52 million).
Earnings per share attributable to stockholders for the nine months ended September 30, 2022 amounted to $3.07 relative to 2.32 for the corresponding period in 2021. The EPS for the quarter was reported at $1.05 relative to $0.67 reported in 2021. The twelve months trailing EPS is $3.98. The number of shares used in our calculations is 733,546,855. SEP closed the trading period on November 15, 2022 at $70.26 with a corresponding P/E of 17.63 times.
Balance Sheet at a Glance:
As at September 30, 2022, the company’s total assets increased 115.9% to $80.81 billion from $37.43 billion a year ago. The upward movement was due to an increase in ‘Property, Plant & Equipment’ and ‘Inventories’ which closed the period at $20.36 billion (2021: $7.55 billion) and $20.27 billion (2021: $7.43 billion), respectively.
Shareholders’ equity for the period was $27.92 billion relative to $18.13 billion last year. As such, resulting in a book value per share of $38.06 relative to $24.72 last year.
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may affect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.